Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Curcumin in MASLD and Type 2 Diabetes Treatment
October 2025
A 12-month randomised controlled trial investigated curcumin supplementation in Type 2 diabetes treatment, specifically its effects on liver steatosis.
Read more
22 Oct 2025
Curcumin in MASLD and Type 2 Diabetes Treatment
A 12-month randomised controlled trial investigated curcumin supplementation in Type 2 diabetes treatment, specifically its effects on liver steatosis.
18 Oct 2025
NOD1 Signalling in Acute Liver Failure
The study examined transcriptome data from patients with HBV-induced acute liver failure and healthy controls, identifying key genes and pathways linked to disease progression.
14 Oct 2025
COVID-19 Risks for Patients with Chronic Liver Disease
Interestingly, liver transplant recipients did not experience excess mortality, likely due to restored liver function post-transplant.
10 Oct 2025
Optimising outcomes in advanced PAD treatment
Discover a study highlighting how small-incision large-expansion improves PAD treatment outcomes, offering safer, faster stone removal and preserved sphincter function.
8 Oct 2025
Immune Dysfunction in Liver Cirrhosis Progression
This investigation examined 72 patients with hepatitis virus infection or alcohol-related liver disease across various stages, providing a detailed picture of immune changes in cirrhosis.
6 Oct 2025
MASLD Outcomes Improved with Tirzepatide and Semaglutide
For individuals with MASLD and Type 2 diabetes, these findings suggest that tirzepatide and semaglutide could play a significant role in reducing liver-related complications
4 Oct 2025
Simple Blood Test Predicts Hepatocellular Carcinoma Survival
Crucially, these trends were observed for overall survival as well and were successfully reproduced in the separate validation set.
2 Oct 2025
Viral Hepatitis Screening and Universal Detection Strategies
Traditionally, most European and Spanish guidelines recommend viral hepatitis screening only in individuals with recognised risk factors or elevated liver enzyme levels.
Loading posts...
1
2
3
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View